A proteomic approach for the identification of vascular markers of liver metastasis.
about
Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice.Label-free quantification using MALDI mass spectrometry: considerations and perspectives.Targeting of drugs and nanoparticles to tumors.Direct detection of biotinylated proteins by mass spectrometryAdvances in tenascin-C biology.Immunocytokines: a novel class of products for the treatment of chronic inflammation and autoimmune conditions.Peptides as targeting elements and tissue penetration devices for nanoparticles.Proteomics and the dynamic plasma membrane: Quo Vadis?Metastasis-associated cell surface oncoproteomics.Proteomics in investigation of cancer metastasis: functional and clinical consequences and methodological challenges.Antibody-based delivery of interleukin-2 to neovasculature has potent activity against acute myeloid leukemia.Tumor angiogenesis revisited: Regulators and clinical implications.Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells.An atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemia.Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins.Alternative transcription of a shorter, non-anti-angiogenic thrombospondin-2 variant in cancer-associated blood vessels.Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cellsImmunocytokines
P2860
Q30436623-28F02F94-2D13-4A6C-8814-C0CB60977C85Q31049038-65BC517B-B93C-4838-986A-31AB4AA62FD7Q33751710-1EFA9F3F-06A1-4873-BE30-E888B511E908Q34141688-ABBF088B-7D72-4FDA-94AE-A586E8FA3307Q35214557-67E1B592-B580-4B3A-B069-0133809B5BFBQ37485709-91D91588-B150-4C8E-9124-2CBFDDCF9D33Q37627407-52EFCC42-BFB0-48E5-B2CE-E4C3CF9F4C68Q37809828-4A51AFB5-E43F-47BD-BA4E-DA38FED741A0Q38060714-A6FECAF0-0FAD-4359-8205-A01378257DA0Q38165894-7D1B2CEA-7606-4F91-8EA9-B19D24CE2877Q39100229-6564F054-94D5-4AAB-9F73-0551C36DA8E4Q39393740-A74899A8-6F11-4115-ADFA-3DF09A8873AEQ41835329-70BDCD52-44C4-4776-97AF-CF214511B196Q45869295-4ADB292E-6539-40D2-8D5D-C0B102F8686DQ47277628-26CCE347-087B-4EB2-A83D-84AEA6045805Q52691490-445FC562-7E98-4B4D-9494-2975FA8B60CDQ57463786-BCBF22BE-0D32-479B-8010-17052E39216BQ57911975-45DB9D08-D003-46DB-80E6-3596957AE41C
P2860
A proteomic approach for the identification of vascular markers of liver metastasis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A proteomic approach for the identification of vascular markers of liver metastasis.
@ast
A proteomic approach for the identification of vascular markers of liver metastasis.
@en
type
label
A proteomic approach for the identification of vascular markers of liver metastasis.
@ast
A proteomic approach for the identification of vascular markers of liver metastasis.
@en
prefLabel
A proteomic approach for the identification of vascular markers of liver metastasis.
@ast
A proteomic approach for the identification of vascular markers of liver metastasis.
@en
P2093
P50
P1433
P1476
A proteomic approach for the identification of vascular markers of liver metastasis.
@en
P2093
Beatrice Borgia
Christoph Schliemann
Marta Cesca
P304
P356
10.1158/0008-5472.CAN-09-2939
P407
P577
2009-12-08T00:00:00Z